MannKind Corporation (NASDAQ:MNKD) currently has a daily average trading volume of 3.31M but it saw 2950104 shares traded on Thursday. With a market cap of 1.19B USD, stock’s current market price of $4.55 came falling about -3.40 while comparing to the previous closing price of $4.71. In past 52 weeks, the stock remained buoying in the range of price level as high as $5.73 and as low as $2.91. In the recent trading on the day, stock has struck highest price mark of $4.71 while lowest mark touched by it was $4.53.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
Sponsored
Taking a look at 20-day trading activity of MannKind Corporation (MNKD) gives us an average price of $4.26, while its current price level is -20.59% below from 52-week high level whereas it is 56.36% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $4.13 while that of 200 days or SMA-200 reads an average of $4.26. A closer look into the stock’s movement over the week reveals that its volatility is standing at 4.05% during that period while stretching the period over a month that increases to 5.07%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 56.59 which implies that the stock is in neutral territory.
Over the week, MNKD’s stock price is moving -0.22% down while it is 18.80% when we observe its performance for the past one month. Year-to-date it is -13.66% down and over the past year, the stock is showing an upside performance of 13.75%.
The company is expected to be releasing its next quarterly report in 08/09/2023, for which analysts forecasted an EPS of $Mallinckrodt plc while estimate for next year EPS is $Healthcare.
Currently, MannKind Corporation’s total number of outstanding shares is 263.97M with 2.36% of that held by the insiders while 52.68% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -50.40% and return on equity (ROE) at 28.70%. It has a 30.33 of forward P/E ratio. Stock’s beta reads 1.54. Stock has a price to sale or P/S ratio amounts to 9.24. Its return on asset (ROA) is -24.30% on average.
A filing at the U.S. Securities and Exchange Commission revealed that SPDR S&P Biotech ETF came shrinking its share ownership by 1.78% in the MannKind Corporation (MNKD) increasing its stake to 4.51% with control over 0.21 million shares in the company.
